Why insider trading matters?
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Why insider trading matters?
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral valve diseases, as well as various procedure-enabling platforms to advance minimally invasive surgery. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
---|---|---|---|---|---|---|---|
2022-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO | Sell | 32,550 | $94.82 | $3,086,494 | Yes |
2022-05-10 | Wood Larry L | CVP, TAVR | Sell | 7,242 | $96.13 | $696,181 | Yes |
2022-05-09 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | Sell | 11,560 | $98.24 | $1,135,709 | Yes |
2022-05-04 | Szyman Catherine M. | CVP, Critical Care | Sell | 23,400 | $104.86 | $2,453,828 | Yes |
2022-04-29 | MUSSALLEM MICHAEL A | Chairman & CEO | Sell | 32,550 | $107.80 | $3,508,849 | Yes |
2022-04-28 | Marsh Martha H. | Director | Sell | 28,722 | $108.09 | $3,104,564 | Yes |
2022-04-11 | Szyman Catherine M. | CVP, Critical Care | Sell | 20,000 | $122.04 | $2,440,814 | Yes |
2022-04-08 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | Sell | 11,660 | $123.30 | $1,437,622 | Yes |
2022-04-08 | BOBO DONALD E JR | CVP, Strategy/Corp Development | Sell | 11,050 | $123.34 | $1,362,906 | Yes |
2022-03-22 | MUSSALLEM MICHAEL A | Chairman & CEO | Sell | 32,550 | $112.36 | $3,657,321 | Yes |
2022-03-14 | Szyman Catherine M. | CVP, Critical Care | Sell | 20,000 | $104.65 | $2,093,001 | Yes |
2022-03-11 | BOBO DONALD E JR | CVP, Strategy/Corp Development | Sell | 11,050 | $106.00 | $1,171,355 | Yes |
2022-03-08 | WANG HUIMIN | CVP, Japan & Intercontinental | Sell | 3,675 | $107.60 | $395,430 | Yes |
2022-02-18 | Szyman Catherine M. | CVP, Critical Care | Sell | 20,000 | $106.31 | $2,126,253 | Yes |
2022-02-15 | MUSSALLEM MICHAEL A | Chairman & CEO | Sell | 32,550 | $110.09 | $3,583,289 | Yes |
2022-02-11 | BOBO DONALD E JR | CVP, Strategy/Corp Development | Sell | 11,050 | $111.49 | $1,231,924 | Yes |
2022-02-08 | GALLAHUE KIERAN | Director | Sell | 32,256 | $110.79 | $3,573,510 | Yes |
2022-02-08 | Wood Larry L | CVP, TAVR | Sell | 4,386 | $109.55 | $480,481 | Yes |
2022-02-08 | WANG HUIMIN | CVP, Japan & Intercontinental | Sell | 6,350 | $110.20 | $699,770 | Yes |
2022-01-28 | BOBO DONALD E JR | CVP, Strategy/Corp Development | Sell | 11,050 | $101.15 | $1,117,681 | Yes |
2022-01-14 | Szyman Catherine M. | CVP, Critical Care | Sell | 10,000 | $119.53 | $1,195,263 | Yes |
2022-01-07 | WANG HUIMIN | CVP, Japan & Intercontinental | Sell | 6,350 | $122.16 | $775,716 | Yes |
2022-01-06 | MUSSALLEM MICHAEL A | Chairman & CEO | Sell | 32,550 | $123.88 | $4,032,200 | Yes |
2021-12-20 | MUSSALLEM MICHAEL A | Chairman & CEO | Sell | 32,550 | $119.12 | $3,877,383 | Yes |
2021-12-17 | Szyman Catherine M. | CVP, Critical Care | Sell | 10,000 | $121.24 | $1,212,400 | Yes |
2021-12-10 | Wood Larry L | CVP, TAVR | Sell | 7,830 | $121.49 | $951,267 | Yes |
2021-12-10 | BOBO DONALD E JR | CVP, Strategy/Corp Development | Sell | 11,050 | $121.51 | $1,342,646 | Yes |
2021-12-10 | WANG HUIMIN | CVP, Japan & Intercontinental | Sell | 6,350 | $121.50 | $771,519 | Yes |
2021-11-29 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | Sell | 100 | $110.58 | $11,058 | Yes |
2021-11-24 | VALERIANI NICHOLAS J | Director | Buy | 1,500 | $112.23 | $168,345 | No |
Insider Smart
Insider Smart